Sponsored Projects Administration

Notice of National Cancer Institute (NCI) and National Heart, Lung, and Blood Institute (NHLBI) Participation in PAR-14-210 "Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UH2/UH3)"

Published June 17, 2014 by OSP


The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) and the National Heart, Lung, and Blood Institute (NHLBI) are participating, effective immediately, in: PAR-14-210 "Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UH2/UH3)".

Read More